| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.023 | 0.7 |